Decentralized science in practice: bringing genomics, distributed compute, and rare-disease research on-chain to make research faster, more open, and more collaborative.

NFgenes is a DeSci project focused on integrating genome research with web3 technologies, providing open-source tools and platforms for decentralized scientific collaboration.

In this week's episode of DevNTell, Developer DAO members Vinny and josevelez.eth introduce NFgenes, a DeSci project aimed at bringing genome research to web3. They discuss the project's goals and resources for developers in the web3 space.

NFgenes

Lilypad is a decentralized compute network powering use-cases from DeSci, AI-Agents, and everything in between.

In this week's episode of DevNTell, we are joined by Allison Haire (CEO) and Stanley Bishop (DeSci OG & Head of Research) from Lilypad. Lilypad is a decentralized compute network powering use-cases from DeSci, AI-Agents, and everything in between. Viewers will see Allison and Stanley give an overview of Lilypad, why it was built, the use-cases it can empower, and how to get started using it today.

Powering the AI-driven science revolution with Lilypad

Rare Compute is a pioneering decentralized biotech platform that aims to revolutionize rare disease research by leveraging blockchain technology and computing credits.

In this week's episode of DevNTell we will be joined by Stanley Bishop whose Co-Founder of Rare Compute. Rare Compute is a pioneering decentralized biotech platform that aims to revolutionize rare disease research by leveraging blockchain technology and computing credits. Viewers of this DevNTell will see Stanley give us an overview of Rare Compute, why it was started and their latest research helping to fight against rare disease. Brought to you by our friends at Arbitrum DAO

Rare Compute, Fighting Rare Disease with AI & Web3

AminoChain is a community-owned infrastructure built to make research faster, more transparent, and more inclusive.

In this week's episode of DevNTell we will be joined by Caspar Barnes who is the Founder and CEO of AminoChain. AminoChain is a community-owned infrastructure built to make research faster, more transparent, and more inclusive. Viewers of this DevNTell will get to meet Caspar, learn the story behind AminoChain and more!

Building Trust in Science with AminoChain ft. CEO Caspar Barnes

Fighting Rare Disease on Undiagnosed Day | Stanley Bishop & Mikk Cederroth - Episode focusing on rare diseases, undiagnosed conditions, AI in medicine, and community-driven research initiatives.

In this episode of DevNTell we are joined by Stanley Bishop and Mikk Cederroth. Stanley is currently affiliated with “Research to the People,” a joint program between Stanford Genetics and Stanford Medicine, where he contributes his AI expertise and leadership to unite a diverse set of collaborators tackling unaddressed problems in rare genetic illness medicine and precision oncology. Mikk, alongside his wife Helene, is the founder behind the Wilhelm Foundation, a global voice dedicated to ending the diagnostic odyssey for people living with undiagnosed diseases (PLWUD). Viewers of this DevNTell will get to meet Stanley and Mikk, learn about Undiagnosed Day, insights into rare disease research, and more.

Fighting Rare Disease on Undiagnosed Day | Stanley Bishop & Mikk Cederroth

Decentralized science: research funding, biotech, rare-disease, and verifiable science.